Title: Ceftriaxone versus Cefotaxime in the Treatment of Septicemia in Adults
Abstract: Two potent third-generation cephalosporins with similar antibacterial spectra but different pharmacokinetics were compared in patients suffering from septicemia due to different organismus. Sixty patients with a variety of underlying diseases were included in the study. They received either 2–4 g ceftriaxone (active ingredient of RocephinTM) once a day or 2 g cefotaxime every 8 h for 10–15 days. Our data confirm that a single dose of 2 g ceftriaxone should be sufficient to treat septicemia.
Publication Year: 1989
Publication Date: 1989-01-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 3
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot